Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Retinoblastoma × Hyperthermia, Induced × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Urinary Bladder Neoplasms 2 Breast Neoplasms 2 Uveal Melanoma 1 Ureteral Neoplasms 1 Retinoblastoma 1 Prostatic Neoplasms 1 Neoplasm Metastasis 1 Hyperthermia 1 Hematologic Neoplasms 1

Interventions

Carboplatin 19 Etoposide 17 Vincristine 13 Melphalan 10 Filgrastim 10 Granulocyte Colony-Stimulating Factor 9 Topotecan 8 Cyclophosphamide 8 Thiotepa 6 Mesna 4 Cryotherapy 4 Busulfan 4 Radiotherapy 3 Peripheral Blood Stem Cell Transplantation 3 Ifosfamide 3 Drug Therapy 3 Doxorubicin 3 Temozolomide 2 Eye Enucleation 2 Cisplatin 2 Brachytherapy 2 trioctyl phosphine oxide 1 sargramostim 1 racotumomab 1 pembrolizumab 1 pegylated granulocyte colony-stimulating factor 1 pegfilgrastim 1 etoposide phosphate 1 cixutumumab 1 becatecarin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04681417 2025-11-28

RETINO 2018

Institut Curie

Phase 2/3 Recruiting

Other solid neoplasm

Retinoblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡